Alkem Laboratories Stock Forecast

Stock Price Forecast

According to 20 analysts polled by S&P Global, Alkem Laboratories stock has a consensus rating of "Hold" and an average price target of ₹5,956. The average 1-year stock price forecast is 12.43% higher than the current stock price, while the lowest is ₹4,200 (-20.72%) and the highest is ₹6,890 (+30.05%).

Price Target: ₹5,956 (+12.43%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	₹4,200	₹5,956	₹6,118	₹6,890
Change	-20.72%	+12.43%	+15.47%	+30.05%

Analyst Ratings

The average analyst rating for Alkem Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Apr '26	May '26	Jun '26
Strong Buy	4	4	5	5	6	6
Buy	6	6	6	6	6	6
Hold	6	6	7	7	4	4
Sell	2	2	0	0	0	0
Strong Sell	3	3	3	3	4	4
Total	21	21	21	21	20	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bansi Desai J.P. Morgan	J.P. Morgan	Hold Maintains ₹5,900	Hold	Maintains	₹5,900	+11.36%	May 29, 2026
Alok Dalal Jefferies	Jefferies	Buy Maintains ₹6,500	Buy	Maintains	₹6,500	+22.69%	May 29, 2026
Abdulkader Puranwala ICICI Securities	ICICI Securities	Buy Maintains ₹6,500 → ₹6,850	Buy	Maintains	₹6,500 → ₹6,850	+29.29%	May 28, 2026

Financial Forecast

Revenue This Year

165.55B

from 147.12B

12.53%

from 147.12B

Revenue Next Year

182.53B

from 165.55B

10.25%

from 165.55B

EPS This Year

197.22

from 204.53

-3.57%

from 204.53

EPS Next Year

226.39

from 197.22

14.79%

from 197.22

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	106.34B	115.99B	126.68B	129.65B	147.12B	165.55B
Revenue Growth	19.96%	9.08%	9.21%	2.34%	13.48%	12.53%
Gross Profit	63.54B	65.79B	76.03B	80.39B	96.20B	106.95B
Gross Margin	59.75%	56.72%	60.02%	62.01%	65.38%	64.60%
Operating Income	17.43B	13.20B	19.68B	21.52B	26.23B	29.66B
Net Income	16.46B	9.84B	17.96B	21.65B	23.02B	23.92B
EPS	-	-	-	-	204.53	197.22
EPS Growth	-	-	-	-	12.93%	-3.57%
Forward PE	23.64	26.11	28.26	24.55	27.02	26.86
Dividend / Share	34.00	25.00	40.00	45.00	53.00	51.49
Dividend Growth	-	-26.47%	60.00%	12.50%	17.78%	-2.85%
Free Cash Flow	-6.09B	5.55B	30.97B	6.35B	13.74B	18.12B
No. Analysts	-	-	-	-	-	19

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	170.2B
Avg	165.6B
Low	162.2B

Revenue Growth

Revenue Growth	2027	2028	2029
High	15.7%
Avg	12.5%
Low	10.3%

EPS Forecast

EPS	2027	2028	2029
High	211.60
Avg	197.22
Low	186.10

EPS Growth

EPS Growth	2027	2028	2029
High	3.5%
Avg	-3.6%
Low	-9.0%